Last Updated: March 26, 2020, 7:30am EDT
As a medical device manufacturer, we are committed to minimizing any disruption to the supply of our products to our customers globally, during this unprecedented time with the outbreak of COVID-19. We are in weekly discussions with our supply chain to assess the potential impact of COVID-19 and to take appropriate actions to mitigate risks as they emerge. As most of our supply base is in North America, we are able to be in close communications during this time.
We are reviewing and establishing protocols and guidelines to minimize any adverse impact of COVID-19 on our employees, our sites, and our supply. We cannot deliver on our products without prioritizing the safety and wellness of our employees. We have implemented several measures including suspension of all business-related travel, facility access restrictions and work from home where possible including our customer facing teams.
As you know, the situation is fluid as the world tries to contain the spread of the virus. We have established a task force to monitor this ever-evolving situation and our leadership team is meeting every day to take necessary actions to keep our employees safe and to facilitate uninterrupted product supply. I am confident that together with our team of dedicated employees, our suppliers, and loyal customers, like you, we will overcome this storm.
If you have any questions or concerns about the continued delivery of our high-quality products, please contact our dedicated Customer Service Team at customerservice [at] trudellmed.com.
Vice President and General Manager,
Trudell Medical International
March 26, 2020
Trudell Medical UK Limited
A message from our President
Trudell Medical UK Limited’s (TMUK) mission is to help respiratory patients breathe better and live fuller lives. In the fight against 2019 Novel Coronavirus (COVID-19) our thoughts are with those individuals and families whose lives have been affected and with those healthcare professionals providing essential care in these unprecedented times.
At the time of writing this the UK government has advised 1.5 million people with serious health conditions to remain at home to stay safe for the next 12 weeks. Groups being shielded include people with severe respiratory conditions including cystic fibrosis, non-cystic fibrosis bronchiectasis, severe asthma and severe COPD.
Read the complete letter...
April 30, 2020